Brief: Medicenna Reports Second Quarter Fiscal 2023 Financial Results
04/11/2022 11:11
Nov 4 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS SECOND QUARTER FISCAL 2023 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* MEDICENNA THERAPEUTICS CORP - QTRLY LOSS PER SHARE $0.01
* MEDICENNA THERAPEUTICS - $40 MILLION IN CASH, CASH
EQUIVALENTS,
AND MARKETABLE SECURITIES AT SEPTEMBER 30, 2022, PROVIDES RUNWAY
INTO Q2 CALENDAR 2024
Source text for Eikon: ID:nGNXtM50P
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results